FDA “Approvable” Letter Requests Validation, Stability Data For Merck’s Emend IV
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm will respond “within the next few months” to May 3 letter, Merck tells “The Pink Sheet” DAILY.